Literature DB >> 19883624

Adenosine receptors interacting proteins (ARIPs): Behind the biology of adenosine signaling.

Francisco Ciruela1, Catarina Albergaria, Aroa Soriano, Laura Cuffí, Lourdes Carbonell, Silvia Sánchez, Jorge Gandía, Víctor Fernández-Dueñas.   

Abstract

Adenosine is a well known neuromodulator in the central nervous system. As a consequence, adenosine can be beneficial in certain disorders and adenosine receptors will be potential targets for therapy in a variety of diseases. Adenosine receptors are G protein-coupled receptors, and are also expressed in a large variety of cells and tissues. Using these receptors as a paradigm of G protein-coupled receptors, the present review focus on how protein-protein interactions might contribute to neurotransmitter/neuromodulator regulation, based on the fact that accessory proteins impinge on the receptor/G protein interaction and therefore modulate receptor functioning. Besides affecting receptor signaling, these accessory components also play a key role in receptor trafficking, internalization and desensitization, as it will be reviewed here. In conclusion, the finding of an increasing number of adenosine receptors interacting proteins, and specially the molecular and functional integration of these accessory proteins into receptorsomes, will open new perspectives in the understanding of particular disorders where these receptors have been proved to be involved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19883624     DOI: 10.1016/j.bbamem.2009.10.016

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  20 in total

Review 1.  On the expanding terminology in the GPCR field: the meaning of receptor mosaics and receptor heteromers.

Authors:  Luigi F Agnati; Diego Guidolin; Jean Pierre Vilardaga; Francisco Ciruela; Kjell Fuxe
Journal:  J Recept Signal Transduct Res       Date:  2010-10       Impact factor: 2.092

Review 2.  Age-dependent decline in neurogenesis of the hippocampus and extracellular nucleotides.

Authors:  Yoshinori Takei
Journal:  Hum Cell       Date:  2019-02-07       Impact factor: 4.174

Review 3.  Adenosinergic signaling as a target for natural killer cell immunotherapy.

Authors:  Jiao Wang; Sandro Matosevic
Journal:  J Mol Med (Berl)       Date:  2018-08-01       Impact factor: 4.599

Review 4.  Purinergic system in psychiatric diseases.

Authors:  A Cheffer; A R G Castillo; J Corrêa-Velloso; M C B Gonçalves; Y Naaldijk; I C Nascimento; G Burnstock; H Ulrich
Journal:  Mol Psychiatry       Date:  2017-09-26       Impact factor: 15.992

5.  Conserved disulfide bond is not essential for the adenosine A2A receptor: Extracellular cysteines influence receptor distribution within the cell and ligand-binding recognition.

Authors:  Andrea N Naranjo; Amy Chevalier; Gregory D Cousins; Esther Ayettey; Emily C McCusker; Carola Wenk; Anne S Robinson
Journal:  Biochim Biophys Acta       Date:  2014-11-16

6.  In vitro pharmacological profile of the A2A receptor antagonist istradefylline.

Authors:  Mayumi Saki; Koji Yamada; Etsuko Koshimura; Katsutoshi Sasaki; Tomoyuki Kanda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-29       Impact factor: 3.000

7.  Sequential synthesis and methylation of phosphatidylethanolamine promote lipid droplet biosynthesis and stability in tissue culture and in vivo.

Authors:  Gerd Hörl; Andrea Wagner; Laura K Cole; Roland Malli; Helga Reicher; Petra Kotzbeck; Harald Köfeler; Gerald Höfler; Sasa Frank; Juliane G Bogner-Strauss; Wolfgang Sattler; Dennis E Vance; Ernst Steyrer
Journal:  J Biol Chem       Date:  2011-03-22       Impact factor: 5.157

Review 8.  Metabolic Aspects of Adenosine Functions in the Brain.

Authors:  Mercedes Garcia-Gil; Marcella Camici; Simone Allegrini; Rossana Pesi; Maria Grazia Tozzi
Journal:  Front Pharmacol       Date:  2021-05-14       Impact factor: 5.810

9.  Adenosine A2A Receptor Activation Enhances Blood-Tumor Barrier Permeability in a Rodent Glioma Model.

Authors:  Amélie Vézina; Monica Manglani; DreeAnna Morris; Brandon Foster; Matthew McCord; Hua Song; Meili Zhang; Dionne Davis; Wei Zhang; Jessica Bills; Kunio Nagashima; Priya Shankarappa; Jessica Kindrick; Stuart Walbridge; Cody J Peer; William D Figg; Mark R Gilbert; Dorian B McGavern; Leslie L Muldoon; Sadhana Jackson
Journal:  Mol Cancer Res       Date:  2021-09-14       Impact factor: 6.333

10.  ADORA1 is a diagnostic-related biomarker and correlated with immune infiltrates in papillary thyroid carcinoma.

Authors:  Xu Lin; Zhi-Yong Wang; Gang Xue; Xiao-Jing Qin; Jing-Fang Wu; Geng Zhang
Journal:  J Cancer       Date:  2021-05-13       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.